Treatment-resistant diseases characterized by excessive activation of the JAK/STAT pathway, elevated serum levels of JAK-dependent cytokines, along with JAK/STAT mutations mainly include autoimmune diseases, malignant tumors, graft-versus-host disease (GVHD), and infectious diseases. This evidence concerns the gene SOAT1 and autoimmune disease.